Does NIVOLUMAB Cause Off label use? 5,208 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,208 reports of Off label use have been filed in association with NIVOLUMAB (OPDIVO). This represents 5.9% of all adverse event reports for NIVOLUMAB.
5,208
Reports of Off label use with NIVOLUMAB
5.9%
of all NIVOLUMAB reports
1,240
Deaths
1,725
Hospitalizations
How Dangerous Is Off label use From NIVOLUMAB?
Of the 5,208 reports, 1,240 (23.8%) resulted in death, 1,725 (33.1%) required hospitalization, and 344 (6.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 5,208 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
Dyspnoea (2,527)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which NIVOLUMAB Alternatives Have Lower Off label use Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE